НовостиBenzingaLeerink Partners Maintains Outperform on Medline, Raises Price Target to $46 Leerink Partners Maintains Outperform on Medline, Raises Price Target to $46 Benzinga 2026.11.05 20:17 (GMT+0) Открыть на Benzinga Другие новости